Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
Public ClinicalTrials.gov record NCT02582697. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether accelerated BEP chemotherapy is more effective than standard BEP chemotherapy in males with intermediate and poor-risk metastatic germ cell tumours.
Study identification
- NCT ID
- NCT02582697
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 500 participants
Conditions and interventions
Conditions
Interventions
- Bleomycin (active name: Bleomycin Sulfate) Drug
- Etoposide Drug
- Cisplatin Drug
- Pegylated G-CSF (Pegfilgrastim) Drug
- Filgrastim Drug
Drug
Eligibility (public fields only)
- Age range
- 11 Years to 50 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2014
- Primary completion
- Dec 30, 2029
- Completion
- Dec 30, 2029
- Last update posted
- Aug 31, 2026
2014 – 2029
United States locations
- U.S. sites
- 21
- U.S. states
- 9
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kaiser Permanente Downey Medical Center | Downey | California | — | Recruiting |
| Loma Linda University Medical Center | Loma Linda | California | — | Recruiting |
| Miller Children's and Women's Hospital Long Beach | Long Beach | California | — | Recruiting |
| Los Angeles General Medical Center | Los Angeles | California | — | Recruiting |
| USC / Norris Comprehensive Cancer Center | Los Angeles | California | — | Recruiting |
| Lucile Packard Children's Hospital Stanford University | Palo Alto | California | — | Recruiting |
| Stanford Cancer Institute Palo Alto | Palo Alto | California | — | Recruiting |
| Rady Children's Hospital - San Diego | San Diego | California | — | Recruiting |
| Ann and Robert H Lurie Children's Hospital of Chicago | Chicago | Illinois | — | Recruiting |
| University of Illinois | Chicago | Illinois | — | Recruiting |
| Advocate Children's Hospital-Oak Lawn | Oak Lawn | Illinois | — | Recruiting |
| Advocate Children's Hospital-Park Ridge | Park Ridge | Illinois | — | Recruiting |
| Johns Hopkins University/Sidney Kimmel Cancer Center | Baltimore | Maryland | — | Recruiting |
| Dana-Farber/Harvard Cancer Center | Boston | Massachusetts | — | Recruiting |
| Washington University School of Medicine | St Louis | Missouri | — | Recruiting |
| Memorial Sloan Kettering Cancer Centre | New York | New York | 10065 | Recruiting |
| Ohio State University Comprehensive Cancer Center | Columbus | Ohio | — | Recruiting |
| Driscoll Children's Hospital | Corpus Christi | Texas | — | Recruiting |
| UT Southwestern/Simmons Cancer Center-Dallas | Dallas | Texas | 75235 | Recruiting |
| University of Texas Health Science Center at San Antonio | San Antonio | Texas | — | Recruiting |
| Primary Children's Hospital | Salt Lake City | Utah | — | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 35 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02582697, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 31, 2026 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02582697 live on ClinicalTrials.gov.